MMGH/Thomas Cherian

2017

—

Ongoing

Market Information for Access to Vaccine (MI4A) Initiative

Since 2017, MMGH has provided ongoing support to the WHO Expanded Program on Immunization's MI4A initiative aimed at enhancing countries’ access to safe, effective, quality, and affordable vaccines. MMGH ...

Client:

World Health Organization (WHO)

​

2019

—

2019

Implementing the Ending Cholera: A Global Roadmap to 2030 Strategy

MMGH assisted the Global Task Force on Cholera Control (GTFCC), on a Bill & Melinda Gates Foundation grant, in establishing an Oral Cholera Vaccine (OCV) demand forecast platform, a programme performance ...

Client:

Global Task Force on Cholera Control (GTFCC)

​

2020

—

2021

COVID-19 Support to World Health Organization

MMGH is supporting the Country Readiness and Delivery (CRD) workstream of the COVAX Facility, under the vaccines pillar of the ACT Accelerator, through technical support to the WHO & UNICEF Regional Offices, ...

Client:

World Health Organization

​

2019

—

2019

Improving access to affordable vaccine supply in Member States of the South-Eastern Europe Health Network

MMGH supported the Vaccine-Preventable Diseases and Immunisation Unit of WHO Europe in operationalising the South-Eastern Europe Health Network (SEEHN) vision and principles which focus on securing access ...

Client:

World Health Organization (WHO)

CDC

2019

—

2019

Identification of alternative strategies for the Meningitis International Coordinating Group

MMGH supported the International Coordinating Group (ICG) for meningitis to improve access to vaccines for the international stockpile. The project sought to understand the reasons for supply constraints ...

Client:

World Health Organization (WHO)

MMGH/Carsten Mantel

2019

—

2019

Application for Gavi support for human papillomavirus vaccine introduction in Cambodia

MMGH assisted the National Immunization Program (NIP), Ministry of Health Cambodia, and the WHO Country Office in Phnom Penh with the Gavi application process for the introduction of the human papillomavirus ...

Client:

World Health Organization (WHO)